September 19, 2008 – Volcano Corp. will host “The Future of Intravascular Imaging” symposium Tuesday evening, Oct. 14 at ...
Intravascular Imaging
This channel includes news and new technology innovations for intra-vascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging systems used in the cath lab. These imaging modalities help with diagnostic decisions about how to treat atheroscolosis and help guide device placement and verification of stent apposition. The technology also is used to visualize in-stent restenosis.
The FDA has approved the LipiScan Coronary Imaging System, an angiography laser scanner by InfraReDx Inc., which ...
September 03, 2008
Boston Scientific launched its Atlantis 018 Peripheral Imaging Catheter, which reportedly brings existing 40MHz coronary ...
September 03, 2008
Feature | Nick Obradovich
The only safe assumption to make about today’s current gold standard imaging modality used to identify and ...
July 09, 2008July 10, 2008 - Boston Scientific Corp. this week launched its Atlantis .018 Peripheral Imaging Catheter, which ...
July 09, 2008May 20, 2008 – Volcano paid $12 million in cash at the closing for the acquisition of Novelis Inc., a privately-held ...
May 19, 2008May 8, 2008 – The first human procedure using the Volcano OCT imaging catheter, which uses optical coherence ...
May 07, 2008
InfraReDx Inc. developed the LipiScan Coronary Imaging System that is intended to characterize fatty deposits in ...
April 28, 2008April 29, 2008 - The FDA has approved the LipiScan Coronary Imaging System, an angiography laser scanner by ...
April 28, 2008April 11, 2008 - St. Jude Medical will acquire EP MedSystems for approximately $92.1 million in a deal that will ...
April 10, 2008
Volcano Corp. offers the s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access to ...
March 10, 2008
A third round of software enhancements has been made to the iLab System 1.3, an ultrasound imaging system ...
February 10, 2008
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow ...
February 07, 2008February 7, 2008 - Volcano Corp. said the FDA cleared the s5-Revo and s5-FFR (fractional flow reserve) options, enabling ...
February 07, 2008February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow ...
February 07, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now